Association of metformin with breast cancer incidence and mortality in patients with type 2 diabetes: a GRADE assessed systematic review and meta-analysis.


BACKGROUND Preclinical data suggests that metformin may reduce breast cancer incidence and improve cancer prognosis. However, the current evidence in observational studies is inconclusive. A systematic review and meta-analysis was conducted to assess the effect of metformin on the incidence of breast cancer and all-cause mortality in patients with type 2… (More)
DOI: 10.1158/1055-9965.EPI-17-0936


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.